116 related articles for article (PubMed ID: 38433050)
21. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
Zhang W; McElhinny A; Nielsen A; Wang M; Miller M; Singh S; Rueger R; Rubin BP; Wang Z; Tubbs RR; Nagle RB; Roche P; Wu P; Pestic-Dragovich L
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):54-61. PubMed ID: 20881839
[TBL] [Abstract][Full Text] [Related]
22. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches.
Romeo S; Bovée JV; Kroon HM; Tirabosco R; Natali C; Zanatta L; Sciot R; Mertens F; Athanasou N; Alberghini M; Szuhai K; Hogendoorn PC; Dei Tos AP
Virchows Arch; 2012 Nov; 461(5):561-70. PubMed ID: 23001328
[TBL] [Abstract][Full Text] [Related]
23. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of radiological and clinicopathological features of craniofacial fibro-osseous lesions].
Yang XD; Xu G; Song LH; Zhu H; Liu X; Li FH; Peng SK; Ma ZY; Zhou H
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):122-128. PubMed ID: 32074723
[No Abstract] [Full Text] [Related]
26. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
27. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
[TBL] [Abstract][Full Text] [Related]
28. MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones.
Bahceci DH; Jordan RCK; Horvai AE
Head Neck Pathol; 2022 Dec; 16(4):991-997. PubMed ID: 35546651
[TBL] [Abstract][Full Text] [Related]
29. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
30. MDM2 dual-color in situ hybridization (DISH) aids the diagnosis of intimal sarcomas.
Jimbo N; Komatsu M; Itoh T; Hirose T
Cardiovasc Pathol; 2019; 43():107142. PubMed ID: 31442826
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.
Gardner JM; Dandekar M; Thomas D; Goldblum JR; Weiss SW; Billings SD; Lucas DR; McHugh JB; Patel RM
Am J Surg Pathol; 2012 Jul; 36(7):1047-51. PubMed ID: 22472959
[TBL] [Abstract][Full Text] [Related]
32. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
35. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract][Full Text] [Related]
37. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
38. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
[TBL] [Abstract][Full Text] [Related]
39. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
40. Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.
Makise N; Sekimizu M; Kubo T; Wakai S; Watanabe SI; Kato T; Kinoshita T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Histopathology; 2018 Jul; 73(1):147-156. PubMed ID: 29489027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]